Table 2.
Cases | Percent Ipsilateral* | Controls | OR (95% CI) | |
---|---|---|---|---|
BBD Histologic Subtype and extent of atypia | ||||
Non-proliferative | 108 | 51.3 | 680 | 1.0 (ref) |
Proliferative without atypia | 256 | 54.9 | 1035 | 1.6 (1.3-2.1) |
AH, 1 focus† | 37 | 62.5 | 66 | 3.8 (2.4-6.1) |
AH, 2 foci | 26 | 54.6 | 42 | 4.5 (2.6-7.7) |
AH, ≥3 foci | 56 | 59.1 | 74 | 5.3 (3.5-8.1) |
Among cases with available laterality data (N=387).
** Adjusted for matching factors (age at breast cancer diagnosis, year of benign breast biopsy, and time since BBD biopsy) and family history of breast cancer, age at menarche, parity/age at first birth, body mass index, menopausal status/type of menopause, and duration of postmenopausal hormone use.
Number of cases/controls included in foci analysis (119 cases, 182 controls) does not add up to total number of cases/controls with AH (124 cases, 192 controls) due to missing foci information.
p-trend, number of foci of AH = 0.22